Chemoradiotherapy in head and neck cancer;Chimioradiotherapies des carcinomes des voies aerodigestives superieures

Cancer/Radiotherapie

Volumn 2, Issue 6, 1998, Pages 679-688

  Bourhis, J ^a   Calais, G ^b   Eschwege F ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b CHU BRETONNEAU   (France)

Author keywords

Carcinoma; Chemotherapy; Head and neck; Radiation therapy

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; HYDROXYUREA; MERCAPTOPURINE; METHOTREXATE; MITOMYCIN; PACLITAXEL; TEGAFUR; TIRAPAZAMINE; VINCRISTINE; VINDESINE; RADIOSENSITIZING AGENT;

CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HEAD AND NECK CANCER; HUMAN; META ANALYSIS; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; REVIEW; SURVIVAL RATE; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; HEAD AND NECK TUMOR; MORTALITY; MULTIMODALITY CANCER THERAPY; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; NEOADJUVANT THERAPY; RADIATION-SENSITIZING AGENTS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0032287286     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(99)80008-0     Document Type: Article

References (70)

1. 1 Adelstein D, Sharan V, Earle S. Simultaneous versus sequential combined therapy for squamous cell head and neck cancer. Cancer 1990 ; 65 : 1685-91
2. 2 Al Sarraf M, LeBlanc M, Giri P, Fu K. Chemo-radiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J Clin Oncol 1998 ; 16 : 1310-7
3. 3 Altun M, Fandi A, Dupuis O, Cvitkovic E, Krajina Z, Eschwege F. Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects. Int J Radiat Oncol Biol Phys 1995 ; 32 : 859-77
4. 4 Amer M, Bull C, Daouk N, McArthur P. A prospective randomized trial of chemotherapy with platinum vincristine and bleomycin followed by radiotherapy versus radiotherapy alone for advanced head and neck cancer [abstract]. Proc Am Soc Clin Oncol 1983 ; 3 : 625
5. 5 Archangeli G, Nervi C, Righini R, Creton G, Miri MA, Guerra A. Combined radiation and drugs: the effect of intra-arterial chemotherapy followed by radiotherapy in head and neck cancer. Radiother Oncol 1983 ; 1 : 101-7
6. 6 Bachaud JM, David JM, Boussin G, Daly N. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: preliminary report of a randomised trial. Int J Radiat Oncol Biol Phys 1991 ; 20 : 243-6
7. 7 Bezwoda W, De Moor N, Derman D. Treatment of advanced head and neck cancer by means of radiation therapy plus chemotherapy. A randomised trial. Med Pediat Oncol 1979 ; 6 : 353-8
8. 8 Bourhis J, Eschwege F. Radio-chemotherapy combinations in head and neck squamous cell carcinoma. Anticancer Res 1996 ; 16 : 2397-402
9. 9 Bourhis J, Wibault P, Lusinchi A, Bobin S, Eschwege F. Status of accelerated fractionated radiotherapy in head and neck squamous cell carcinoma. Current Opin Oncol 1997 ; 9 : 262-6
10. 10 Bourhis J, Pignon JP, Domenge C, Designe L, Luboinski M. Metaanalysis of chemotherapy in head and neck squamous cell carcinoma, on behalf of the MACH-NC collaborative group [abstract]. Proc Am Soc Clin Oncol 1998 ; 16 : 1486A
11. 11 Brizel DM, Alsbers M, Fisher S. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. New Eng J Med 1998 ; 338 : 1798-804
12. 12 Browman G, Cripps C, Hodson I, Eapen L, Sathya J, Levine M. Placebo-controlled randomized trial of iv infusional 5 fluorouracil concurrent with standard radiotherapy in stage III and IV head and neck. Proc Am Soc Clin Oncol 1994 ; 12 : 2648-53
13. 13 Brunin F, Rodriguez J, Jaullery C. Induction chemotherapy in advanced head and neck cancer. Acta Oncol 1989 ; 28 : 61-5
14. 14 Calais G, Alfonsi M, Bardet E, Sire C, Bourgeois H, Bergerot C et al. Randomized study comparing radiation alone (RT) versus RT with concomitant chemotherapy (CT) in stages III and IV oropharynx carcinoma (ARCORO). Preliminary results of the 94-01 study from the French Group of Radiation Oncology for Head and Neck Cancer (GORTEC) [abstract]. Proc Am Soc Clin Oncol 1998 ; 16 : A1484
15. 15 Datta N, Chouldhry A, Gupta S. Twice a day versus once a day radiation therapy in head and neck cancer. Int J Radiat Oncol Biol Phys 1989 ; 17 : 132
16. 16 De Crevoisier R, Bourhis J, Domenge C, Koscielny S, Wibault P, Lusinchi A et al. Full dose re-irradiation for unresectable head and neck carcinoma: experience at the Gustave Roussy Institute in a series of 169 patients. J Clin Oncol 1998 ; 16 : 1-9
17. 17 Depondt J, Gehanno P, Martin M. Neoadjuvant chemotherapy with carboplatin/5-Fluorouracil in head and neck cancer. Oncology 1993 ; 50 : 23-7
18. 18 Dimery I, Peters L, Goepfert H, Morrison WH, Byers RM, Guillory C et al. Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma. J Clin Oncol 1993 ; 11 : 1919-28
19. 19 Dobrowsky W, Dobrowsky E, Naudé J. Conventional versus accelerated in advanced head and neck cancer. Br J Cancer 1996 ; suppl 74 : 279-81
20. 20 Eschwege F, Sancho-Garnier H, Gérard JP, Richard JM. Ten-year results of a randomized trial comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx: experience of the EORTC. NCI Monograph 1988 ; 57 : 275-8
21. 21 Fazekas J, Sommer C, Kramer S. Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx or hypopharynx. Concluding reports of an RTOG randomized trial on 638 patients. Int J Radiat Oncol Biol Phys 1980 ; 6 : 533-41
22. 22 Fu K, Phillips T, Silverberg I, Friedman MA, Kohler M, Carter SK. Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group Randomized trial. J Clin Oncol 1987 ; 5 : 1410-8
23. 23 Fu K, Cooper J, Marcial V, Pajak T. Evolution of the radiation therapy oncology group clinical trials for head and neck cancer. Int J Radiat Oncol Biol Phys 1996 ; 35 : 425-38
24. 24 Gupta N, Pointon R, Wilkinson P. A randomized clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously. Clin Radiol 1987 ; 38 : 575-81
25. 25 Haffty B, Son Y, Sasaki C, Fisher R. Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: results from, two randomized clinical trials. Int J Radiat Oncol Biol Phys 1993 ; 27 : 241-50
26. 26 Harraf D, Weichselbaum R, Vokes EE. Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentialy curable disease. Ann Oncol 1996 ; 7 : 913-8
27. 27 Haselow R, Warshaw M, Oken M. Radiation alone versus radiation with weekly low dose cisplatinum in unresectable cancer of the head and neck. In: Fee WE, Goepfert H, Johns M, eds. Head and Neck Cancer, vol II. Philadelphia: Raven Press ; 1990. p 279-81
28. 28 Horiot J C, LeFur, N'Guyen T. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC group of radiotherapy. Radiother Oncol 1992 ; 25 : 231-41
29. 29 Hussey D, Abrams J. Combined therapy in advanced head and neck cancer hydroxyurea and radiotherapy. Prog Clin Cancer 1975 ; 6 : 79-86
30. 30 International Nasopharynx Cancer Study Group* (INCSG). Preliminary results of a randomized trial comparing neoadjuvant chemotherapy plus radiotherapy versus radiotherapy alone in stage IV (N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival VUMCA I Trial. Int J Rad Oncol Biol Phys 1996 ; 35 : 463-9
31. 31 Jaullery C, Rodriguez J, Brunin F. Induction chemotherapy in advanced head and neck tumors: results of two randomised trials. Int J Radiat Oncol Biol Phys 1992 ; 23 : 483-9
32. 32 Jensen OM, Estève J, Moller H, Renard H. Cancer in the European Community and its member states. Eur J Cancer 1990 ; 26 : 1167-256
33. 33 Jelic S, Kovcin V, Milanovic N. Randomized study of zorubicin versus zorubicin-cisplatinum in UCNT. Ann Oncol 1997 ; 8 : 739-41
34. 34 Jeremic C, Shibamoto Y, Stanisavljevic B, Milosevic L, Milicic B, Nikolic N. A randomized trial of concomitant radiotherapy with platinum versus radiotherapy alone in HNSCC. Radiother Oncol 1997 ; 43 : 29-37
35. 35 Keane T, Cummings B, O'Sullivan B. A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1993 ; 25 : 613-8
36. 36 Knowlton A, Percarpio B, Bobrow S, Fischer J. Methotrexate and radiation therapy in the treatment of advanced head and neck tumors. Radiology 1975 ; 116 : 709-12
37. 37 Lefèbvre JL, Wolf G, Luboinski B, Armand JP, Bourhis J, Domenge C et al. On behalf of the MACH-NC collaborative group A metaanalysis on larynx preservation in locally advanced laryngeal and hypopharyngeal cancer [abstract]. Proc Am Soc Clin Oncol 1998 ; 17
38. 38 Lefèbvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Shamoud T. Larynx preservation in piriform sinus cancer: results of the EORTC phase III trial. J Natl Cancer Inst 1996 ; 88 : 890-9
39. 39 Luboinski B. Personal communication on behalf of the GETTEC. Paris : Groupe d'étude des tumeurs de la tête et du cou ; 1998
40. 40 Merlano M, Rosso R, Sertoli M, Corvo M, Vitale V. Randomized comparison of two chemotherapy, radiotherapy scheme for stage III and IV unresectable squamous cell carcinoma of the head and neck. Laryngoscope 1990 ; 100 : 531-42
41. 41 Merlano M, Vitale V, Rosso R, Corvo M. Treatment of advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 1992 ; 327 : 1115-21
42. 42 Morita K. Clinical significance of radiation therapy combined with chemotherapy. Strahlentherapie 1980 ; 156 : 228-33
43. 43 Nissenbaum M, Browde S, Bezwoda W, Demoor RG, Derman DP. Treatment of advanced head and neck cancer; multiple daily dose fractionated radiation therapy and sequential multimodal treatment approach. Med Pediatr Oncol 1984 ; 12 : 204-8
44. 44 Paccagnella A, Orlando A, Marchlori C. A phase III trial of neoadjuvant chemotherapy in head and neck cancer [abstract]. Proc Am Soc Clin Oncol 1993 ; 12 : 894
45. 45 Parvinen L, Parvinen E, Nordman E, Kortekangas. Combined bleomycin treatment and radiation therapy in squamous cell carcinoma of the head and neck region. Acta Radiol Oncol 1985 ; 24 : 487-90
46. 46 Petrovitch Z, Block J, Kuisk H. A randomized comparison of radiotherapy with a radiotherapy-chemotherapy combination in stage IV carcinoma of head and neck. Cancer 1981 ; 47 : 2259-64
47. 47 Pignon JP, Bourhis J, Domenge C. Meta-analysis of chemotherapy in head and neck cancer: individual data versus data of the literature. Br J Cancer 1995 ; 72 : 1063
48. 48 Pinto L, Canary P, Araujo C. Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stage III and IV oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1991 ; 21 : 557-62
49. 49 Richard JM, Sancho H, Lepintre Y, Rodary C, Pierquin B. Intraarterial methotrexate chemotherapy and telecobalt therapy in cancer of the oral cavity and oropharynx. Cancer 1974 ; 34 : 491-6
50. 50 Richard JM, Sancho-Garnier H, Pessy JJ, Luboinski B, Lefèbvre JL, Deshedin D et al Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncology 1998 ; 34 : 224-8
51. 51 Richards G, Chambers R. Hydroxyurea: a radiosensitizer in the treatment of neoplasms of head and neck. Am J Roentgen 1969 ; 105 : 555-65
52. 52 Rossi A, Molinari R, Boracchi P. Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study. J Clin Oncol 1988 ; 6 : 1401-10
53. 53 Salvajoli J, Morioka H, Trippe N, Kowalski A, randomized trial of neoadjuvant versus concomitant versus radiotherapy alone in the treatment of stage IV head and neck squamous cell carcinoma. Eur Arch Oto Rhinol Laryngol 1992 ; 249 : 211-5
54. 54 Sanshiz F, Milla A, Torner J. Single fraction per day versus two fractions per day versus radiochemetherapy in the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys 1990 ; 19 : 1347-50
55. 55 Saunders M, Dische S, Barrett A, Parmar M. Randomized multicentre trial of CHART vs conventional radiotherapy in head and neck and non small cell lung cancer: an interim report. Br J Cancer 1996 ; 73 : 1455-62
56. 56 SEGOG. Randomized trial of combined multidrug chemotherapy and radiotherapy in advanced squamous cell carcinoma of the head and neck. Eur J Surg Oncol 1986 ; 12 : 289-95
57. 57 Shanta V, Krishnamurthi S. Combined bleomycin and radiotherapy in oral cancer. Clin Radiol 1980 ; 31 : 617-20
58. 58 Shetty P, Mehta A, Shinde A, Mazumdar A, Mingorani C. Controled study in squamous cell carcinoma of base of tongue using conventional radiation, radiation with single drug and radiation with multiple drug chemotherapy [abstract]. Proc Am Soc Clin Oncol 1985 ; 5 : 595
59. 59 Stefani S, Eells R, Abbate J. Hydroxyurea and radiotherapy in head and neck cancer result of a prospective controlled study in 126 patients. Radiology 1971 ; 101 ; 391-6
60. 60 Stell P, Dalby J, Strickland, Fraser JG, Bradley PJ, Flood LM. Sequential chemotherapy and radiotherapy in advanced head and neck cancer. Clin Radiol 1983 ; 34 : 463-7
61. 61 Szpirglas H, Nizri D, Marneur M, Lacoste JP, Benslama L. Neoajuvant chemotherapy. A randomized trial before radiotherapy in oral and oropharyngeal carcinoma: end results. In: Proceeding of the second International Conference on head and neck cancer 1987. Arligton, USA : Kugler and Ghedini 29 1988. p 261-4
62. 62 Taylor S, Murthy A, Vannetzel JM, Dray M, Colin P. Randomized comparison of neoadjuvant cisplatinum and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 1994 ; 12 : 385-95
63. 63 Tejedor M, Murias A, Soria P. Induction chemotherapy with carboplatin and floratur in advanced head and neck cancer. A randomized study. Am J Clin Oncol 1992 ; 15 : 417-21
64. 64 Tepmongkoi P. Large intravenous dose of methotrexate and radiotherapy in the treatment of advanced oral cancers. J Med Ass Thailand 1979 ; 62 : 17-24
65. 65 Vermund H, Kaalhus O, Winther F, Traujo J, Thorud E, Harang R. Bleomycin and radiation therapy in squamous cell carcinoma of the upper aero-digestive tract: a phase III clinical trial. Int J Radiat Oncol Biol Phys 1985 ; 11 : 1877-86
66. 66 Vokes E, Kies MS, Haraf K. Intensive concomitant chemoradiotherapy (CT/XRT) for head and neck cancer: high locoregional control and organ preservation rate. Proc Am Soc Clin Oncol 1998 ; 16 : 1485
67. 67 von Essen C, Joseph L, Simon G, Singh A, Singh S. Sequential chemotherapy and radiation therapy of buccal mucosa carcinoma in South India. Am J Roentgen 1968 ; 102 : 530-40
68. 68 Weissberg J, Son Y, Papac R. Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer. Int J Radiat Oncol Biol Phys 1989 ; 17 : 3-9
69. 69 Weissler M, Melin S, Sailer S, Qaqish BF, Rosenman JG, Pillsbury HC. Simultaneous chemoradiation in the treatment of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1992 ; 118 : 806-10
70. 70 Wolf G on behalf of the Veteran Affairs Laryngeal Cancer Study Group (VALCSG). Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Eng J Med 1992 ; 324 : 1685-90